  Acute Lymphoblastic Leukemia (ALL) accounts for the 80% of leukemias when
coming down to pediatric ages. Survival of these patients has increased by a
considerable amount in recent years. However, around 15-20% of treatments are
unsuccessful. For this reason, it is definitely required to come up with new
strategies to study and select which patients are at higher risk of relapse.
Thus the importance to monitor the amount of leukemic cells to predict relapses
in the first treatment phase. In this work we develop a mathematical model
describing the behavior of ALL, examining the evolution of a leukemic clone
when treatment is applied. In the study of this model it can be observed how
the risk of relapse is connected with the response in the first treatment
phase. This model is able to simulate cell dynamics without treatment,
representing a virtual patient bone marrow behavior. Furthermore, several
parameters are related to treatment dynamics, therefore proposing a basis for
future works regarding childhood ALL survival improvement.
